Valeo Financial Advisors LLC Sells 105 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Valeo Financial Advisors LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,874 shares of the healthcare conglomerate’s stock after selling 105 shares during the quarter. Valeo Financial Advisors LLC’s holdings in UnitedHealth Group were worth $7,266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG raised its holdings in UnitedHealth Group by 3.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after buying an additional 9,872 shares during the last quarter. Proficio Capital Partners LLC raised its holdings in UnitedHealth Group by 52.1% in the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate’s stock worth $1,889,000 after buying an additional 1,279 shares during the last quarter. Finally, Machina Capital S.A.S. purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $354,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the company’s stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer directly owned 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last 90 days. 0.28% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research report on Wednesday, May 14th. Baird R W lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 11th. KeyCorp reduced their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research note on Monday, June 2nd. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Finally, TD Securities reissued a “hold” rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $415.57.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $303.75 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a 50 day simple moving average of $322.66 and a two-hundred day simple moving average of $445.65. The stock has a market cap of $275.54 billion, a price-to-earnings ratio of 12.72, a PEG ratio of 1.48 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.91%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.